Prevest Denpro Limited submitted its Investor Presentation for the half year ended September 30, 2026 to BSE Limited in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The presentation contains detailed financial performance and strategic updates.

Financial Performance - Standalone (Q2 FY26-27)

  • Revenue from operations: ₹2,168.44 lakhs
  • Total Income: ₹2,328.99 lakhs
  • EBITDA: ₹914.02 lakhs (39.2% margin)
  • PBT: ₹862.72 lakhs (37.0% margin)
  • PAT: ₹662.57 lakhs (28.4% margin)

Financial Performance - Consolidated (Q2 FY26-27)

  • Revenue from operations: ₹2,164.39 lakhs
  • Total Income: ₹2,318.68 lakhs
  • EBITDA: ₹891.16 lakhs (38.4% margin)
  • PBT: ₹839.22 lakhs (36.2% margin)
  • PAT: ₹639.07 lakhs (27.6% margin)

Year-over-Year Growth (Standalone Q2 FY26-27 vs Q2 FY25-26)

  • Revenue from operations: +16.2%
  • EBITDA: +15.7%
  • PBT: +16.6%
  • PAT: +19.0%

Quarter-over-Quarter Growth (Standalone Q2 FY26-27 vs Q1 FY26-27)

  • Revenue from operations: ₹2,168.44 lakhs vs ₹1,944.33 lakhs (+11.5%)
  • Total Income: ₹2,328.99 lakhs vs ₹2,077.40 lakhs (+12.1%)
  • EBITDA: ₹914.02 lakhs vs ₹821.88 lakhs (+11.2%)
  • PBT: ₹862.72 lakhs vs ₹770.26 lakhs (+12.0%)
  • PAT: ₹662.57 lakhs vs ₹578.23 lakhs (+14.6%)

Half-Yearly Performance (Standalone H1 FY26-27 vs H1 FY25-26)

  • Revenue from operations: ₹4,112.77 lakhs vs ₹3,438.57 lakhs (+19.6%)
  • Total Income: ₹4,406.38 lakhs vs ₹3,676.02 lakhs (+19.9%)
  • EBITDA: ₹1,735.90 lakhs vs ₹1,460.40 lakhs (+18.9%)
  • PBT: ₹1,632.98 lakhs vs ₹1,361.57 lakhs (+19.9%)
  • PAT: ₹1,240.80 lakhs vs ₹1,020.38 lakhs (+21.6%)

Consolidated Half-Yearly Performance (H1 FY26-27 vs H1 FY25-26)

  • Revenue from operations: ₹4,071.22 lakhs vs ₹3,440.84 lakhs (+18.3%)
  • Total Income: ₹4,357.04 lakhs vs ₹3,676.65 lakhs (+18.5%)
  • EBITDA: ₹1,699.29 lakhs vs ₹1,435.21 lakhs (+18.4%)
  • PBT: ₹1,595.10 lakhs vs ₹1,336.01 lakhs (+19.4%)
  • PAT: ₹1,202.92 lakhs vs ₹994.83 lakhs (+20.9%)

Dividend Declaration

  • Interim Dividend: ₹2.10 per share for H1 FY27 (10% of Face Value)
  • Board approval date: November 2026

Business Highlights

  • Export revenue growth: 17.58% in FY26, 14.9% YoY growth in H1 FY27
  • Revenue mix: 41% domestic, 59% export share in H1 FY27
  • R&D expenditure: ₹81.14 lakhs in H1 FY27
  • Manufacturing infrastructure located in Jammu
  • Product portfolio includes Restorative Materials, Endodontic Solutions, Preventive Care, Orthodontic Adhesives, Impression Materials & Cements, Digital Dentistry & Disinfectants

Strategic Initiatives

  • Expansion into digital dentistry and 3D printing solutions
  • Development of in-house 3D printer capabilities and specialized resins
  • Focus on supply chain localization to reduce import dependence
  • Market expansion into Tier II & Tier III domestic markets and new international markets
  • Development of indigenous raw materials

The presentation also highlights growth drivers in the Indian dental consumables market including rising dental awareness, increasing adoption of cosmetic procedures, expansion of clinic chains, and shift towards digital dentistry.